Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ricela Group is a leading Indian conglomerate specializing in the extraction and refining of rice bran oil and the production of rice-derived nutraceuticals. The company is recognized as the world's largest producer of Gamma Oryzanol, a natural bioactive compound used globally in supplements and functional foods to manage cholesterol levels and support cardiovascular health. Operating through its flagship entity Ricela Health Foods and its subsidiary A.P. Organics, the group maintains a vertically integrated supply chain from raw material processing to high-purity chemical extraction. Their product portfolio serves the pharmaceutical, cosmetic, and food industries, emphasizing natural health solutions derived from agricultural byproducts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ricela Group.